{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T16:41:45Z","timestamp":1783528905966,"version":"3.55.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":6661,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1016\/j.fertnstert.2003.08.030","type":"journal-article","created":{"date-parts":[[2004,3,17]],"date-time":"2004-03-17T05:36:34Z","timestamp":1079501794000},"page":"645-651","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Psychological effect of the oral contraceptive formulation containing 3 mg of drospirenone plus 30 \u03bcg of ethinyl estradiol"],"prefix":"10.1016","volume":"81","author":[{"given":"Anna Maria","family":"Paoletti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Lello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Fratta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa","family":"Orr\u00f9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Ranuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiana","family":"Sogliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Concas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Biggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Benedetto","family":"Melis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2003.08.030_BIB1","series-title":"Hormonal contraception","author":"Goldzieher","year":"1994"},{"key":"10.1016\/j.fertnstert.2003.08.030_BIB2","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1073\/pnas.95.6.3239","article-title":"Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine","volume":"95","author":"Uzunova","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.fertnstert.2003.08.030_BIB3","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0006-3223(98)00328-X","article-title":"Concentrations of 3 alpha-reduced neuroactive steroids and their precursors in plasma of patients with major depression and after clinical recovery","volume":"45","author":"Strohle","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.fertnstert.2003.08.030_BIB4","first-page":"1076","article-title":"Relationship between symptom severity and steroid variation in women with premenstrual syndrome","volume":"81","author":"Wang","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2003.08.030_BIB5","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0301-0082(92)90025-A","article-title":"Neurosteroids","volume":"38","author":"Majewska","year":"1992","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.fertnstert.2003.08.030_BIB6","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0165-6147(00)89058-6","article-title":"Neurosteroids and GABAA receptor function","volume":"16","author":"Lambert","year":"1995","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.fertnstert.2003.08.030_BIB7","doi-asserted-by":"crossref","unstructured":"Robel P, Schumacher M, Baulieu EE. Neurosteroids: from definition and biochemistry to physiopathologic function. In: Baulieu EE, Robel P, Schumacher, M, eds. Neurosteroids. A new regulatory function in the nervous system. 1st ed. Totowa, N.J.: Human Press, 1999: chap 1, pp. 1\u201325","DOI":"10.1007\/978-1-59259-693-5_1"},{"key":"10.1016\/j.fertnstert.2003.08.030_BIB8","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0039-128X(98)00101-9","article-title":"Neuropsychopharmacological properties of neuroactive steroids","volume":"64","author":"Rupprecht","year":"1999","journal-title":"Steroids"},{"key":"10.1016\/j.fertnstert.2003.08.030_BIB9","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0006-8993(90)90261-9","article-title":"The neurosteroid dehydroepiandrosterone sulfate is an allosteric antagonist of the GABAA receptor","volume":"526","author":"Majewska","year":"1990","journal-title":"Brain Res"},{"key":"10.1016\/j.fertnstert.2003.08.030_BIB10","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0304-3940(88)90202-9","article-title":"Neurosteroid pregnenolone sulfate antagonizes electrophysiological responses to GABA in neurons","volume":"90","author":"Majewska","year":"1988","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.fertnstert.2003.08.030_BIB11","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0028-3908(01)00187-3","article-title":"Changes in GABAA receptor gamma 2 subunit gene expression induced by long-term administration of oral contraceptives in rats","volume":"42","author":"Follesa","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.fertnstert.2003.08.030_BIB12","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/S0002-9378(12)91807-4","article-title":"New knowledge in the physiology of hormonal contraceptives","volume":"170","author":"Lobo","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2003.08.030_BIB13","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3109\/09513590009167685","article-title":"Inhibition of skin 5 alpha-reductase by oral contraceptive progestins in vitro","volume":"14","author":"Rabe","year":"2000","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2003.08.030_BIB14","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1210\/jcem-73-4-837","article-title":"Dihydrospirorenone, a new progestogen with antimineralocorticoid activity","volume":"73","author":"Oelkers","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2003.08.030_BIB15","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/0010-7824(92)90121-9","article-title":"Dihydrospirorenone (ZK30595)","volume":"46","author":"Pollow","year":"1992","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2003.08.030_BIB16","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0010-7824(94)00015-O","article-title":"Drospirenone","volume":"51","author":"Muhn","year":"1995","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2003.08.030_BIB17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/13625180008500375","article-title":"Efficacy and tolerability of a monophasic oral contraceptive containing ethinylestradiol and drospirenone","volume":"5","author":"Huber","year":"2000","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.fertnstert.2003.08.030_BIB18","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1089\/15246090152543148","article-title":"Evaluation of a unique oral contraceptive in the treatment of premenstrual dysphoric disorder","volume":"10","author":"Freeman","year":"2001","journal-title":"J Womens Health Gend Based Med"},{"key":"10.1016\/j.fertnstert.2003.08.030_BIB19","unstructured":"Derogatis LR, Lipman RS, Covi L. SCL-90: and outpatient psychiatric rating scale: preliminary report. ECDEU assessment manual. DHEW publication. Washington, D.C.: U.S. Government Printing Office, 1996:313\u201331"},{"key":"10.1016\/j.fertnstert.2003.08.030_BIB20","series-title":"Improving access to quality care in family planning\u2014medical eligibility criteria for contraceptive use","year":"1996"},{"key":"10.1016\/j.fertnstert.2003.08.030_BIB21","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/S0028-3908(96)00067-6","article-title":"Isoniazid-induced inhibition of GABAergic transmission enhances neurosteroid content in the rat brain","volume":"35","author":"Barbaccia","year":"1996","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.fertnstert.2003.08.030_BIB22","doi-asserted-by":"crossref","first-page":"4553","DOI":"10.1073\/pnas.88.10.4553","article-title":"Stress-induced elevations of gamma-aminobutyric acid type A receptor-active steroids in the rat brain","volume":"88","author":"Purdy","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.fertnstert.2003.08.030_BIB23","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/S0006-3223(99)00081-5","article-title":"Late onset congenital adrenal hyperplasia","volume":"46","author":"Jacobs","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.fertnstert.2003.08.030_BIB24","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1017\/S0033291799002731","article-title":"Elevated circulatory level of GABA(A)-antagonist neurosteroids in patients with combat-related post-traumatic stress disorder","volume":"30","author":"Spivak","year":"2000","journal-title":"Psychol Med"},{"key":"10.1016\/j.fertnstert.2003.08.030_BIB25","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s007020050077","article-title":"Plasma dehydroepiandrosterone sulfate in unipolar major depression. Short communication","volume":"105","author":"Takebayashi","year":"1998","journal-title":"J Neural Transm"},{"key":"10.1016\/j.fertnstert.2003.08.030_BIB26","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1532-5415.1999.tb01590.x","article-title":"Endogenous levels of dehydroepiandrosterone sulfate, but not other sex hormones, are associated with depressed mood in older women","volume":"47","author":"Barrett-Connor","year":"1999","journal-title":"J Am Geratr Soc"},{"key":"10.1016\/j.fertnstert.2003.08.030_BIB27","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1053\/meta.2000.18522","article-title":"Serum concentrations of estradiol and dehydroepiandrosterone sulfate and soy product intake in relation to psychological well-being in peri and postmenopasual Japanese women","volume":"49","author":"Nagata","year":"2000","journal-title":"Metabolism"},{"key":"10.1016\/j.fertnstert.2003.08.030_BIB28","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0378-5122(02)00030-0","article-title":"Efficacy and safety of oral and transdermal hormonal replacement treatment containing levonorgestrel","volume":"42","author":"Paoletti","year":"2002","journal-title":"Maturitas"},{"key":"10.1016\/j.fertnstert.2003.08.030_BIB29","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1210\/jcem.86.2.7179","article-title":"Evidence that cyproterone acetate improves psychological symptoms and enhances the activity of the dopaminergic system in postmenopause","volume":"86","author":"Paoletti","year":"2001","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028203030462?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028203030462?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T13:27:06Z","timestamp":1777296426000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028203030462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["S0015028203030462"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2003.08.030","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2004,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psychological effect of the oral contraceptive formulation containing 3 mg of drospirenone plus 30 \u03bcg of ethinyl estradiol","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2003.08.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}